维普中文期刊产品整合服务
117篇 您的检索式:作者名="VIRAG L"
    题名 作者 年代 出处 被引量
1A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform显示文摘Bence Sipos Simone M?ser Holger Kalthoff Virag T?r?k Matthias L?hr Günter Kl?ppel 2003Virchows Archiv2003,,5:4
2Interaction of different potassium channels in cardiac repolarization in dog ventricular preparations : role of repolarization reserve 显示文摘Biliczki P Virag L Iost N 2002Br J Pharmacol2002,137,3:1
3Dexmcdctomidine increases tau phosphorylation under normothermic condi- tionsln vivo and in vitro 显示文摘Whittington R A Virag L Gratuze M 2015Neurobiol Aging2015,36,8:1
4The therapeutic potential of poly ( ADP-ribose) polymerase inhibitors 显示文摘Virag L Szabo C 2002Pharmacol Rev2002,54,37:1
5Propofol directly increases tau phosphorylation 显示文摘WHITTINGTON R A VIRAG L MARCOUILLER F 2011PloS One2011,6,1:1
6The therapeutic potential of poly ADP-ribose polymerase inhibitors显示文摘Virag L Szabo C 2006Pharmacol Review2006,58,3:1
7Diabetic endothelial dysfunction : the role of poly ( ADP - ribose) polymcrase activation 显示文摘Garcia SF Virag L Jactap P 2001Nature Med2001,7,1:1
8Peroxynitrite2induced cy to toxicity : mechanism and opportunities for intervention显示文摘Virag L Szabo E Gergely P etal 2003Toxicol Let t2003,140,14:1
9Dexmedetomidine increaSes the cocaine seizure threshold in rats显示文摘Whittington RA Virag L Vulliemoz Y 2002Anesthesiology2002,97,3:1
10The therapeutic potential of poly (ADP- ribose) polymerase inhibitors显示文摘Virag L Szabo C 2002Pharmacol Rev2002,54,3:1
11显示文摘Virag L 1998J Immunol1998,161,:1
12Restricting excessive cardiac action potential and QT prolongation: a vital role or Iks in human ventricu- lar muscle显示文摘Jost N Virag L Bitay M 2005Circulation2005,112,10:1
13Dexmedetomidine decreases extracellular dopamine concentrations in the rat nucleus accumbens 显示文摘WHITTINGTON R A VIRAG L MORISHIMA H O 2001Brain Res2001,919,1:1
14Diabetic endothelial dysfunction:role of reactive oxygen and nitrogen species production and (ADP-ribose) polymerase activation显示文摘Soriano FG Virag L Szabo C 2001J Mol Med2001,79,8:1
15The therapeutic potential of poly(ADP-ribose)polymerase inhibitors显示文摘Virag L Szabo C 2002Pharmacol Rev2002,54,:1
16The therapeutic potential of poly(ADP-ri- bose)polymerase inhibitors显示文摘Virag L Szabo C 2002Pharmacol Rev2002,54,3:1
17The therapeutic potential of poly(ADP-ribose) polymerase inhibitors显示文摘Virag L Szabo C 2002Pharmacol Rev2002,54,3:1
18Analysis of the contribution of Ito to repolarization in canine ventricular myocardium 显示文摘Virag L Jost N Papp R 2011Br J Pharma- col2011,164,1:1
19Evidence for reactive nitro- gen species formation in the gingivomucosal tissue 显示文摘Lohinai Z Stachlewitz R Virag L 2001J Dent Res2001,80,2:1
20Diabetic endothelial dysfunction: the role of poly(ADP - ribose) polymerase activation显示文摘 Virag L Jagtap P 2001Nat Med2001,7,1:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费